Diversity of small molecule HIV‐1 latency reversing agents identified in low‐ and high‐throughput small molecule screens
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diversity of small molecule HIV‐1 latency reversing agents identified in low‐ and high‐throughput small molecule screens
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-10-14
DOI
10.1002/med.21638
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment
- (2019) Ignacio Relaño-Rodríguez et al. JOURNAL OF NANOBIOTECHNOLOGY
- Synthesis and Structure–Activity Relationship Correlations of Gnidimacrin Derivatives as Potent HIV-1 Inhibitors and HIV Latency Reversing Agents
- (2019) Qingbo Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- The HIV Reservoir in Monocytes and Macrophages
- (2019) Michelle E. Wong et al. Frontiers in Immunology
- Novel Latency Reversal Agents for HIV-1 Cure
- (2018) Adam M. Spivak et al. Annual Review of Medicine
- Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV
- (2018) Youry Kim et al. Cell Host & Microbe
- Nanotechnology approaches to eradicating HIV reservoirs
- (2018) Shijie Cao et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Selection of biomarkers for HIV-1 latency by integrated analysis
- (2018) Sun Young Lee et al. GENOMICS
- Histone deacetylase inhibitor chidamide promotes reactivation of latent human immunodeficiency virus by introducing histone acetylation
- (2018) Qiyuan Kuai et al. JOURNAL OF MEDICAL VIROLOGY
- A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other “Shock” Drugs
- (2018) Erik Abner et al. JOURNAL OF VIROLOGY
- Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural Products
- (2018) Khumoekae Richard et al. Viruses-Basel
- Design, synthesis, and biological evaluation of AV6 derivatives as novel dual reactivators of latent HIV-1
- (2018) Mingtao Ao et al. RSC Advances
- BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1
- (2018) Jin Gohda et al. Scientific Reports
- Barriers and strategies to achieve a cure for HIV
- (2018) Matthew C Pitman et al. Lancet HIV
- Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase 2b Trial
- (2018) Sulggi A. Lee et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Strategies for an HIV cure: progress and challenges
- (2018) Fu Sheng Wang et al. NATURE IMMUNOLOGY
- Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency
- (2017) Nancie M. Archin et al. JOURNAL OF CLINICAL INVESTIGATION
- Histone deacetylase inhibitors containing a benzamide functional group and a pyridyl cap are preferentially effective human immunodeficiency virus-1 latency-reversing agents in primary resting CD4+ T cells
- (2017) Yoshifumi Kobayashi et al. JOURNAL OF GENERAL VIROLOGY
- HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency
- (2017) George N. Llewellyn et al. JOURNAL OF NEUROVIROLOGY
- The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling Complexes
- (2017) Ryan J. Conrad et al. MOLECULAR CELL
- Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration–Approved Drugs
- (2017) Nathan P. Coussens et al. PHARMACOLOGICAL REVIEWS
- Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui
- (2017) Pengfei Wang et al. Scientific Reports
- Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation
- (2017) Alberto Bosque et al. Cell Reports
- Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors
- (2017) Christina Gavegnano et al. PLoS Pathogens
- A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association
- (2017) Huachao Huang et al. Frontiers in Microbiology
- The Molecular Basis for Human Immunodeficiency Virus Latency
- (2017) Uri Mbonye et al. Annual Review of Virology
- Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation
- (2017) Brice J. Albert et al. Scientific Reports
- BDDCS, the Rule of 5 and drugability
- (2016) Leslie Z. Benet et al. ADVANCED DRUG DELIVERY REVIEWS
- HIV-1 Latency and Eradication: Past, Present and Future
- (2016) Prasun K. Datta et al. CURRENT HIV RESEARCH
- Bromodomain and extra-terminal (BET) family proteins: New therapeutic targets in major diseases
- (2016) Balasundaram Padmanabhan et al. JOURNAL OF BIOSCIENCES
- Recent Advances in Scaffold Hopping
- (2016) Ye Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site
- (2016) Farhad B. Hashemi et al. JOURNAL OF VIROLOGY
- Activation of HIV-1 expression in latently infected CD4+ T cells by the small molecule PKC412
- (2016) Zhujun Ao et al. Virology Journal
- Tissue reservoirs of HIV
- (2016) Joseph K. Wong et al. Current Opinion in HIV and AIDS
- Shocking HIV out of hiding
- (2016) Thomas A. Rasmussen et al. Current Opinion in HIV and AIDS
- TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection
- (2016) Glen M. Chew et al. PLoS Pathogens
- Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function
- (2016) Matthew Pace et al. PLoS Pathogens
- A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
- (2016) R. Brad Jones et al. PLoS Pathogens
- Targeting the Brain Reservoirs: Toward an HIV Cure
- (2016) Céline Marban et al. Frontiers in Immunology
- Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807
- (2016) Lieven Declercq et al. Molecular Imaging
- Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal
- (2016) Mateusz Stoszko et al. EBioMedicine
- Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents
- (2016) Héloïse M. Delagrèverie et al. Open Forum Infectious Diseases
- Progress and challenges in the use of latent HIV-1 reactivating agents
- (2015) Hong-tao Shang et al. ACTA PHARMACOLOGICA SINICA
- BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency
- (2015) Lars Pache et al. Cell Host & Microbe
- Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1
- (2015) S. Bouchat et al. EMBO Molecular Medicine
- Development and validation of a sensitive HPLC–MS/MS method for determination of chidamide (epidaza), a new benzamide class of selective histone deacetylase inhibitor, in human plasma and its clinical application
- (2015) Ruolan Gu et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques
- (2015) Luca Micci et al. JOURNAL OF CLINICAL INVESTIGATION
- Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations
- (2015) Kai Deng et al. NATURE
- Reactivation of latent HIV-1 provirus via targeting protein phosphatase-1
- (2015) Mudit Tyagi et al. Retrovirology
- 8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential
- (2015) Yu'ning Song et al. MedChemComm
- BRD4 Structure–Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536
- (2015) Lijia Chen et al. ACS Medicinal Chemistry Letters
- Correction: Repressive LTR Nucleosome Positioning by the BAF Complex Is Required for HIV Latency
- (2015) Haleh Rafati et al. PLOS BIOLOGY
- The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
- (2015) Ole S. Søgaard et al. PLoS Pathogens
- Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs
- (2015) Mark A. Brockman et al. Frontiers in Immunology
- Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study
- (2015) Julian H Elliott et al. Lancet HIV
- Bioengineered Vaults: Self-Assembling Protein Shell–Lipophilic Core Nanoparticles for Drug Delivery
- (2014) Daniel C. Buehler et al. ACS Nano
- The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure
- (2014) Jennifer H. Campbell et al. AIDS
- Quantitative Evaluation and Optimization of Co-drugging to Improve Anti-HIV Latency Therapy
- (2014) Victor C. Wong et al. Cellular and Molecular Bioengineering
- “Old Friends in New Guise”: Exploiting Privileged Structures for Scaffold Re-Evolution/Refining
- (2014) Yu'ning Song et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
- (2014) Pietro Ciceri et al. Nature Chemical Biology
- New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
- (2014) C Korin Bullen et al. NATURE MEDICINE
- Discovery of a Small Molecule Agonist of Phosphatidylinositol 3-Kinase p110α That Reactivates Latent HIV-1
- (2014) Geneviève Doyon et al. PLoS One
- Screening for noise in gene expression identifies drug synergies
- (2014) R. D. Dar et al. SCIENCE
- HIV cure research: Advances and prospects
- (2014) Caroline P. Passaes et al. VIROLOGY
- Transcriptional control of HIV latency: Cellular signaling pathways, epigenetics, happenstance and the hope for a cure
- (2014) Uri Mbonye et al. VIROLOGY
- HIV-1 Latency in Monocytes/Macrophages
- (2014) Amit Kumar et al. Viruses-Basel
- Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
- (2014) Thomas A Rasmussen et al. Lancet HIV
- Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells
- (2013) Fiona Wightman et al. AIDS
- Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening
- (2013) Lewis R. Vidler et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
- (2013) N. Okamura et al. JOURNAL OF NUCLEAR MEDICINE
- Reactivation of latent HIV by histone deacetylase inhibitors
- (2013) Kotaro Shirakawa et al. TRENDS IN MICROBIOLOGY
- HIV Latency
- (2013) R. F. Siliciano et al. Cold Spring Harbor Perspectives in Medicine
- An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+ T Cells from Aviremic Patients
- (2013) Celsa A. Spina et al. PLoS Pathogens
- Disulfiram reactivates latent HIV-1 expression through depletion of the phosphatase and tensin homolog
- (2012) Geneviève Doyon et al. AIDS
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
- (2012) Paul D. Ray et al. CELLULAR SIGNALLING
- Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study
- (2012) JP Routy et al. HIV MEDICINE
- Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
- (2012) Liang Shan et al. IMMUNITY
- BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
- (2012) Camellia Banerjee et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets
- (2012) Matthias G. J. Baud et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selected Drugs with Reported Secondary Cell-Differentiating Capacity Prime Latent HIV-1 Infection for Reactivation
- (2012) T. Shishido et al. JOURNAL OF VIROLOGY
- Combination of Biological Screening in a Cellular Model of Viral Latency and Virtual Screening Identifies Novel Compounds That Reactivate HIV-1
- (2012) E. Gallastegui et al. JOURNAL OF VIROLOGY
- Discovery of small molecule cancer drugs: Successes, challenges and opportunities
- (2012) Swen Hoelder et al. Molecular Oncology
- Largazole: From discovery to broad-spectrum therapy
- (2012) Jiyong Hong et al. NATURAL PRODUCT REPORTS
- Shock and kill
- (2012) Steven G. Deeks NATURE
- The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation
- (2012) Zichong Li et al. NUCLEIC ACIDS RESEARCH
- Small Molecules Targeted to a Non-Catalytic “RVxF” Binding Site of Protein Phosphatase-1 Inhibit HIV-1
- (2012) Tatiana Ammosova et al. PLoS One
- Developing strategies for HIV-1 eradication
- (2012) Christine M. Durand et al. TRENDS IN IMMUNOLOGY
- Reactivation of Latent HIV-1 by Inhibition of BRD4
- (2012) Jian Zhu et al. Cell Reports
- HDAC inhibitors in HIV
- (2011) Fiona Wightman et al. IMMUNOLOGY AND CELL BIOLOGY
- Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation
- (2011) Sifei Xing et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High-throughput Screening Uncovers a Compound That Activates Latent HIV-1 and Acts Cooperatively with a Histone Deacetylase (HDAC) Inhibitor
- (2011) Sofiya Micheva-Viteva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- New Insights into the Control of HIV-1 Transcription: When Tat Meets the 7SK snRNP and Super Elongation Complex (SEC)
- (2011) Nanhai He et al. Journal of Neuroimmune Pharmacology
- Structural Basis of the Antiproliferative Activity of Largazole, a Depsipeptide Inhibitor of the Histone Deacetylases
- (2011) Kathryn E. Cole et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation
- (2011) S. Xing et al. JOURNAL OF VIROLOGY
- Protein Phosphatase-1 Activates CDK9 by Dephosphorylating Ser175
- (2011) Tatiana Ammosova et al. PLoS One
- Activation of Latent HIV Using Drug-Loaded Nanoparticles
- (2011) Michael Kovochich et al. PLoS One
- Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells In vitro and In vivo
- (2010) H. Zhang et al. CANCER RESEARCH
- Caffeic acid phenethyl ester inhibits nuclear factor-κB and protein kinase B signalling pathways and induces caspase-3 expression in primary human CD4+ T cells
- (2010) L.-C. Wang et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Privileged scaffolds for library design and drug discovery
- (2010) Matthew E Welsch et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Disulfiram Attenuates Drug-Primed Reinstatement of Cocaine Seeking via Inhibition of Dopamine β-Hydroxylase
- (2010) Jason P Schroeder et al. NEUROPSYCHOPHARMACOLOGY
- Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection
- (2010) Nancie M. Archin et al. PLoS One
- Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir
- (2009) Nathalie Sagot-Lerolle et al. AIDS
- Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
- (2009) Nancie M. Archin et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity
- (2009) D. Rudolph et al. CLINICAL CANCER RESEARCH
- Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
- (2009) Xavier Contreras et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The T-cell-receptor signaling network
- (2009) M. Huse JOURNAL OF CELL SCIENCE
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
- (2009) Nicolas Chomont et al. NATURE MEDICINE
- Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection
- (2009) Sophie Reuse et al. PLoS One
- "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence
- (2009) Andrea Savarino et al. Retrovirology
- Reactive oxygen species activate HIV long terminal repeat via post-translational control of NF-κB
- (2008) Chul-Woong Pyo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
- (2008) Nagma Khan et al. BIOCHEMICAL JOURNAL
- Factors Controlling Chromatin Organization and Nucleosome Positioning for Establishment and Maintenance of HIV Latency
- (2008) Ivan Sadowski et al. CURRENT HIV RESEARCH
- Structure and Activity of Largazole, a Potent Antiproliferative Agent from the Floridian Marine CyanobacteriumSymplocasp.
- (2008) Kanchan Taori et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Structural Basis of Protein Kinase C Isoform Function
- (2008) Susan F. Steinberg PHYSIOLOGICAL REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started